Stock 2Q5 RENOVARO INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Renovaro Inc. Deutsche Boerse AG

Equities

2Q5

US29350E1047

Delayed Deutsche Boerse AG
Other stock markets
 02:16:58 2024-06-03 EDT 		5-day change 1st Jan Change
1.338 EUR +1.67% Intraday chart for Renovaro Inc. +5.35% -53.22%
05-24 Renovaro, Amsterdam UMC Cancer Center Plan to Form Joint Venture for Cancer Immunotherapy MT
05-24 Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Renovaro, Amsterdam UMC Cancer Center Plan to Form Joint Venture for Cancer Immunotherapy
Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy
Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy
Renovaro Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024
Renovaro : Material Event - Form 8-K
Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics
Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics
RENOVARO - RENOVAROCUBE TO ACQUIRE 100% OWNERSHIP OF CYCLOMICS, REINFORCING CUTTING-EDGE CANCER DIAGNOSTICS PARTNERSHIP
Renovaro's RenovaroCube Amends Agreement to Acquire 100% Stake in Cyclomics
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership
Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient Care
Renovaro Inc. Announces Geert Kazemier, MD, PhD, as the New Chairman of its Scientific Advisory Board
Renovaro Inc. Appoints Simon Tarsh as Interim Chief Financial Officer
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB
Renovaro Inc. Announces Resignation of Luisa Puche as Chief Financial Officer, Effective as of March 21, 2024
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB
ROSEN, LEADING INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RENB Stock
  4. 2Q5 Stock
  5. News Renovaro Inc.
  6. Other languages